GLP-1R and Diabetes
US$ 19.99
glp-1 mimetics Non-insulin injectable antidiabetic drugs - agonists and amylinomimetics Mechanisms by which GLP-1 agonists
Description
Pharmaceutical companies largely set their own list prices
[1] Alternative Options When GLP-1 Treatment Fails When GLP-1 medications prove ineffective despite optimisation, several alternative therapeutic strategies exist, depending on whether the primary goal is diabetes management or weight loss
Amylin agonism Amylin is co-secreted with insulin from the -cells of the pancreas and plays a key role in postprandial satiety regulation (Fig
An emerging candidate for this are GLP-1 receptor agonists such as semaglutide and liraglutide
